To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Excedrin is an over-the-counter headache pain reliever, typically in the form of tablets or caplets. It contains acetaminophen, aspirin, and caffeine. Until late 2005 it was manufactured by Bristol-Myers Squibb, but in July 2005 it was purchased by (and is now produced by) Novartis, along with other products from BMS's over-the-counter business. It is one of the top ten selling over-the-counter medicine brands in the United States .
The brand became famous after advertisements in which Excedrin cured especially unpleasant and excruciating headaches (which were termed in the advertisements as "Excedrin headaches," later called "Excedrin tension headaches"). The advertisements, which first started in the 1960s , continue today.
In 2007, the brand branched out into marketing for other types of pains with the introduction of Excedrin Back & Body, which removed the caffeine from the normal mixture.
Additional recommended knowledge
Over the years, different types of the drug were introduced:
As with all medications containing acetaminophen, the use of alcohol with Excedrin carries a significant risk of hepatotoxicity. Additionally, aspirin usage is associated with increased risk of gastrointestinal bleeding.
In 2005, Bristol-Myers Squibb and announced the sale of its North American consumer medicine business (including Excedrin, Comtrex and Keri brands) to Novartis for 660 million dollars, in order to focus on drugs for ten most profitable disease areas .
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Excedrin". A list of authors is available in Wikipedia.|